Improving Outcomes of Hospitalized Elders and Caregivers

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Bethel Powers, University of Rochester
ClinicalTrials.gov Identifier:
NCT00178412
First received: September 12, 2005
Last updated: June 13, 2012
Last verified: June 2012
  Purpose

In this study, an intervention is tested that is designed to improve the outcomes of hospitalized elders and family caregivers.

Study design:

  • randomized, controlled study
  • participants: 280 family caregivers aged 21 or above
  • length of follow-up: 2 weeks and 2 months after hospitalization

Study hypothesis: In this randomized clinical trial, the following hypotheses will be tested:

  1. Hospitalized elders whose family CGs receive the CARE program versus those who receive a comparison program will have better outcomes during and after hospitalization as measured by: (1) fewer incidents of dysfunctional syndrome; (2) shorter hospital stays; (3) lower readmission rates; (4) less depressive symptoms; (5) higher cognitive level; (6) less functional decline perceived by family CG; and (7) a closer relationship with their family CGs.
  2. Family CGs of hospitalized elders who receive the CARE program will report: (1) More positive beliefs about their loved one's responses to hospitalization and their role in the hospital setting; (2) more positive emotional outcomes (less worry, anxiety, and depressive symptoms) during and after hospitalization; (3) More participation in their loved one's care during hospitalization; and (4) More positive role outcomes (more role reward, less role strain, more prepared for their loved one's care, and a closer relationship with their elderly relatives, both during and after hospitalization).
  3. The proposed model to explain the effects of the CARE program on the process and outcomes of family CG coping and elderly patient outcomes will be supported for CGs and elderly patients.

Condition Intervention Phase
Acute Illness
Behavioral: Care Project for Hospitalized Elders & Family Caregivers
Behavioral: Comparison Group
Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: Improving Outcomes of Hospitalized Elders and Caregivers

Resource links provided by NLM:


Further study details as provided by University of Rochester:

Primary Outcome Measures:
  • Patients' outcomes: rates of dysfunctional syndrome, readmission rate, and depression. [ Time Frame: At intake, 1-3 days pre-hospital discharge, at 2 weeks and at 2 months post hospital discharge ] [ Designated as safety issue: No ]
  • Family Caregiver: emotional coping (worry, anxiety and depression); functional coping (participation in patient's care); and role outcomes(role reward, role strain) [ Time Frame: 1-3 days pre-hospital discharge, at 2 weeks and at 2 months post hospital discharge ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Cost analysis. [ Time Frame: At intake, 1-3 days pre-hospital discharge, at 2 weeks and at 2 months post hospital discharge ] [ Designated as safety issue: No ]

Enrollment: 421
Study Start Date: April 2003
Study Completion Date: March 2009
Primary Completion Date: April 2006 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Treatment group
Behavioral: Care Project for Hospitalized Elders & Family Caregivers

Phase 1 in-hospital contact: Family caregivers complete baseline data, listen to a tape about helping the elderly relative cope with hospitalization, and work on a mutual agreement/identification of goals for participation in family member's hospital care (i.e., selection of two complications to focus on based on patient's illness condition)

Phase 2 pre-hospital discharge: Family caregivers listen to a second tape about coping with the hospital experience, participating in their family member's in-hospital care, and preparing for hospital discharge/transition to home

Active Comparator: 2
Comparison Group
Behavioral: Comparison Group

Phase 1 in-hospital contact: Family caregivers complete baseline data and listen to an informational tape about hospital policies.

Phase 2 pre-hospital discharge: Family caregivers listen to a second informational tape about the hospital and medical center.


Detailed Description:

More than 12 million elderly people are hospitalized each year in the United Status, frequently resulting in functional decline. Family care of hospitalized elders is important given the increasing numbers of hospitalized elders, needs for elder care in the home after hospital discharge, and responsibilities of family caregivers for providing this care. Involving family caregivers in the hospital care of their loved one may result in positive outcomes for both the elderly patients and their family caregivers. However, there is a paucity of empirical studies that have been conducted to evaluate the effectiveness of interventions to enhance family participation in caring for hospitalized elders. In the proposed study, we will build upon our prior work that has demonstrated the positive effects of theoretically-driven interventions with families of hospitalized patients and older adults at home. Among the unique contributions of this study include: (a) a randomized controlled design, (b) testing of a theoretically-driven, reproducible intervention that can be easily translated into clinical practice and widely disseminated; (c) the testing of an explanatory model to explain the effects of the intervention, (d) a prospective cost-effectiveness analysis; and (e) an intervention that begins early in the hospital stay, and (f) measurement of both short- and more long-term outcomes, up to 2 months following hospital discharge.

The primary aim of this study is to evaluate the effects of a theoretically-driven, reproducible intervention (CARE: Creating Avenues for Relative Empowerment) on the process and outcomes of hospitalized elders and their family caregivers. The secondary aims are to: (a) explore what factors moderate the effects of the intervention program (e.g., social economic status and family preferences for care participation); and (b) determine the cost-effectiveness of the CARE program. A two-group experiment will be used with 280 family caregivers of hospitalized elders. Measures of both process and outcome variables will be included, such as family caregiver beliefs, anxiety, worry, depression, role outcomes, as well as elderly patients outcomes during hospitalization and after hospital discharge. Findings from a recent pilot study with 49 family caregiver-elders dyads support undertaking this full-scale clinical trial in that family caregivers who received the CARE program, versus those who received a comparison program, had more positive coping and role outcomes and their hospitalized elderly relatives had positive outcomes during and after hospitalization.

  Eligibility

Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:Family CGs

  • age of 21 years or above;
  • have an elderly relative (65 years or above) admitted to the three study units within the past 24-48 hours; (c) are related to the patient by blood, marriage, adoption, or affinity as a significant other (e.g., life partner, close friend);
  • are primary CGs;
  • can read and speak English; and
  • live within a 1-hour drive of the facility (60 miles).

Exclusion Criteria: Family CGS

  • paid care providers;
  • unable to complete the questionnaires or provide care because of their own mental or physical impairment;

Patient:

  • dies during the hospital stay or within 2 months after discharge;
  • is transferred from the Intensive Care Unit (ICU) and stayed in the ICU for more than 2 nights;
  • is diagnosed with dementia;
  • is admitted from a long-term care facility; and
  • is hospitalized for longer than 30 days
  • is staying longer than 6 weeks in a nursing home immediately after hospitalization.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00178412

Locations
United States, New York
University of Rochester School of Nursing
Rochester, New York, United States, 14642
Sponsors and Collaborators
University of Rochester
Investigators
Principal Investigator: Hong Li, Ph.D., RN University of Rochester School of Nursing
Principal Investigator: Bethel A Powers, RN, PhD University of Rochester School of Nursing